Abstract

This retrospective analysis of 526 sickle cell clinical trials examines disparities in the inclusion of very young pediatric patients and the impact of participation demographics on study outcomes and scientific success, providing guidance for nursing advocacy for vulnerable populations in clinical trial design and recruitment.

Description

44th Biennial Convention 2017 Theme: Influence Through Action: Advancing Global Health, Nursing, and Midwifery.

Author Details

Katherine Young, SN; Jessica Keim-Malpass, PhD -- School of Nursing, University of Virginia, Charlottesville, Virginia, USA

Sigma Membership

Beta Kappa

Lead Author Affiliation

University of Virginia, Charlottesville, Virginia, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Clinical Trial, Disparities, Pediatrics

Conference Name

44th Biennial Convention

Conference Host

Sigma Theta Tau International

Conference Location

Indianapolis, Indiana, USA

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (203 kB)

Share

COinS
 

Inclusion of children under 3 years in sickle cell clinical trials: Implications for nurse scientists

Indianapolis, Indiana, USA

This retrospective analysis of 526 sickle cell clinical trials examines disparities in the inclusion of very young pediatric patients and the impact of participation demographics on study outcomes and scientific success, providing guidance for nursing advocacy for vulnerable populations in clinical trial design and recruitment.